Required inspections were not performed on finished product prior to release and distribution.
Source facts
Action
The firm notified the single customer via telephone call on 05/20/2025 and it was followed up with a letter emailed on 05/29/2025. The notification instructed the customer to segregate and quarantine the component immediately and return the implant component in question within 2 business days of acknowledgment of notification. The component was returned on 05/22/2025.
Distributors have responsibility for maintaining field inventory and are responsible for the inventory, even if located on site at a hospital as the products are not purchased/owned by the hospital or patient prior to implantation.
Initiated
2025-05-20
Root cause
Process control
Distribution
US Nationwide distribution in the state of Maryland.
Recall number
Z-2042-2025
Recall status
Open, Classified
CDRH record ID
214202
FDA classified
2025-06-27
Recall event number
97005
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.